TYK2 :p.Pro1104Ala Variant Protects Against Autoimmunity by Modulating Immune Cell Levels

ABSTRACT The TYK2:p.Pro1104Ala (rs34536443) hypomorph variant has been associated with protection against numerous autoimmune disorders. Thus, its mechanism of action becomes of great interest. Here, consistent with the participation of activated immune cells in autoimmunity, we show that the varian...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Immunology Ročník 174; číslo 4; s. 462 - 469
Hlavní autoři: Steri, Maristella, Orrù, Valeria, Sidore, Carlo, Mulas, Antonella, Pitzalis, Maristella, Busonero, Fabio, Maschio, Andrea, Serra, Valentina, Dei, Mariano, Lai, Sandra, Virdis, Francesca, Lobina, Monia, Loizedda, Annalisa, Marongiu, Michele, Masala, Marco, Floris, Matteo, Curreli, Nicolò, Balaci, Lenuta, Loi, Francesco, Pilia, Maria Grazia, Delitala, Alessandro, Fiorillo, Edoardo, Schlessinger, David, Zoledziewska, Magdalena
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Wiley Subscription Services, Inc 01.04.2025
John Wiley and Sons Inc
Témata:
ISSN:0019-2805, 1365-2567, 1365-2567
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:ABSTRACT The TYK2:p.Pro1104Ala (rs34536443) hypomorph variant has been associated with protection against numerous autoimmune disorders. Thus, its mechanism of action becomes of great interest. Here, consistent with the participation of activated immune cells in autoimmunity, we show that the variant regulates the levels of immune cells at a human, general population level and is associated particularly with higher levels of T and B lymphocytes, especially the naïve (non‐activated) compartment. Also, consistent with a protective function in autoimmunity, the level of regulatory CD4+ T cells was increased. Thus, this variant decreases immune activation thereby protecting from autoimmunity. Our work links the cellular mechanism regulated by the TYK2:p.Pro1104Ala variant to autoimmunity protection and supports TYK2 as a therapeutic target in autoimmunity. TYK2:p.Pro1104Ala variant confers protection from several autoimmune disorders but predisposes to infection and we show that the mechanism of its action includes an increase of the levels of lymphocytes in all compartments (CD4+, CD8+ and B), but these cells are mainly naive. Thus, this variant constrains immune activation thereby protecting from autoimmunity. Our work identifies the cellular mechanisms of regulation by the TYK2:p.Pro1104Ala variant providing novel hypotheses for the general immune mechanisms of protection from autoimmunity.
Bibliografie:This work was supported by Intramural Research Program of the National Institute of Aging (HHSN271201100005C, 75N95021C00012), Italian Foundation for Multiple Sclerosis—FISM—Fondazione Italiana Sclerosi Multipla (Grant cod. 2019/S/03) and financed or co‐financed with the ‘5 per mille’ public funding. Sardinia Autonomous Region and its regional agency for research and development in Sardinia—Sardegna Ricerche and local Lanusei government for continues support.
Funding
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Funding: This work was supported by Intramural Research Program of the National Institute of Aging (HHSN271201100005C, 75N95021C00012), Italian Foundation for Multiple Sclerosis—FISM—Fondazione Italiana Sclerosi Multipla (Grant cod. 2019/S/03) and financed or co‐financed with the ‘5 per mille’ public funding. Sardinia Autonomous Region and its regional agency for research and development in Sardinia—Sardegna Ricerche and local Lanusei government for continues support.
ISSN:0019-2805
1365-2567
1365-2567
DOI:10.1111/imm.13902